Valproate-induced parkinsonism, glial cells and Alexander's disease

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 32, Issue 5, 2008, Pages 1351-1352

  Sechi, Gian Pietro ^a   Conti, Maurizio ^a   Sau, Gian Franco ^a   Cocco, Giovanni Antonio ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

VALPROIC ACID;

ADULT; ALEXANDER DISEASE; BRADYKINESIA; CASE REPORT; CLINICAL FEATURE; DRUG DOSE INCREASE; DRUG WITHDRAWAL; FEMALE; GLIA CELL; HUMAN; LETTER; MINI MENTAL STATE EXAMINATION; MUSCLE RIGIDITY; MYOCLONUS; PARKINSONISM; PATHOPHYSIOLOGY; SYMPTOMATOLOGY; UNIFIED PARKINSON DISEASE RATING SCALE;

ADULT; ALEXANDER DISEASE; ANTICONVULSANTS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; NEUROGLIA; PARKINSONIAN DISORDERS; VALPROIC ACID;

EID: 49849084233     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2008.03.022     Document Type: Letter

References (10)

1. Caroli F., Biancheri R., Seri M., Rossi A., Pessagno A., Bugiani M., et al. GFAP mutations and polymorphisms in 13 unrelated Italian patients affected by Alexander disease. Clin Genet 72 (2007) 427-433
2. Chen P.S., Peng G.S., Li G., Yang S., Wu X., Wang C.C., et al. Valproate protects dopaminergic neurons in midbrain neuron/glia cultures by stimulating the release of neurotrophic factors from astrocytes. Mol Psychiatry 11 12 (2006) 1116-1125
3. Easterford K., Clough P., Kellett M., Fallon K., and Duncan S. Reversible parkinsonism with normal beta-CIT-SPECT in patients exposed to sodium valproate. Neurology 62 (2004) 1435-1437
4. Fennrich S., Ray D., Nau H., and Schlosshauer B. Radial astrocytes: toxic effects induced by antiepileptic drug in the developing rat hippocampus in vitro. Eur J Cell Biol 77 (1998) 142-150
5. Friedman J.H., and Ambler M. Progressive parkinsonism associated with Rosenthal fibers: senile-onset Alexander's disease?. Neurology 42 (1992) 1733-1735
6. Li R., Johnson A.B., Salomons G.S., van der Knaap M.S., Rodriguez D., Boespflug-Tanguy O., et al. Propensity for paternal inheritance of de novo mutations in Alexander disease. Hum Genet 119 1-2 (2006) 137-144
7. Maragakis N.J., and Rothstein J.D. Mechanisms of Disease: astrocytes in neurodegenerative disease. Nat Clin Pract Neurol 2 (2006) 679-689
8. Masmoudi K., Gras-Champel V., Masson H., and Andrèjak M. Parkinsonism and/or cognitive impairment with valproic acid therapy: a report of ten cases. Pharmacopsychiatry 38 (2005) 1-4
9. Ristic A.J., Vojvodic N., Jankovic S., Sindelic A., and Sokic D. The frequency of reversible parkinsonism and cognitive decline associated with valproate treatment: a study of 364 patients with different types of epilepsy. Epilepsia 47 (2006) 2183-2185
10. Sobaniec-Lotowska M.E. Ultrastructure of astrocytes in the cortex of the hippocampal gyrus and in the neocortex of the temporal lobe in experimental valproate encephalopathy and after valproate withdrawal. Int J Exp Pathol 84 (2003) 115-125